Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PPAR-γ Gene Expression in Human Adipose Tissue Is Associated with Weight Loss After Sleeve Gastrectomy

  • Torres, Jorge L.
  • Usategui-Martín, Ricardo
  • Hernández-Cosido, Lourdes
  • Bernardo, Edgar
  • Manzanedo-Bueno, Laura
  • Hernández-García, Ignacio
  • Mateos-Díaz, Ana-María
  • Rozo, Orlando
  • Matesanz, Nuria
  • Salete-Granado, Daniel
  • Chamorro, Antonio-Javier
  • Carbonell, Cristina
  • García-Macia, Marina
  • González-Sarmiento, Rogelio
  • Sabio, Guadalupe
  • Muñoz-Bellvis, Luís
  • Marcos, Miguel
Background: The peroxisome proliferator-activated receptor (PPAR)-γ plays a key role in adipose tissue differentiation and fat metabolism. However, it is unclear which factors may regulate its expression and whether obese patients have changes in adipose tissue expression of PPAR-γor potential regulators such as miR-27. Thus, our aims were to analyze PPAR-γ and miR-27 expression in adipose tissue of obese patients, and to correlate their levels with clinical variables. Subjects and methods: We included 43 morbidly obese subjects who underwent sleeve gastrectomy (31 of them completed 1-year follow-up) and 19 non-obese subjects. mRNA expression of PPAR-γ1 and PPAR-γ2, miR-27a, and miR-27b was measured by qPCR in visceral and subcutaneous adipose tissue. Clinical variables and serum adipokine and hormone levels were correlated with PPAR-γ and miR-27 expression. In addition, a systematic review of the literature regarding PPAR-γ expression in adipose tissue of obese patients was performed. Results: We found no differences in the expression of PPAR-γ and miR-27 in adipose tissue of obese patients vs. controls. The literature review revealed discrepant results regarding PPAR-γ expression in adipose tissue of obese patients. Of note, we described a significant negative correlation between pre-operative PPAR-γ1 expression in adipose tissue of obese patients and post-operative weight loss, potentially linked with insulin resistance markers. Conclusion: PPAR-γ1 expression in adipose tissue is associated with weight loss after sleeve gastrectomy and may be used as a biomarker for response to surgery, This work was funded by the following grants to M.M.: ISCIII and FEDER, PI10/01692, PI16/01548, RD16/0017/0023, and I3SNS-INT12/049, L.H.C.: Junta de Castilla y León GRS 681/A/11, J.-L. T.: GRS 1587/A/17 and GRS1356/A/16, G.S.: ERC 260464, EFSD 2030, MICINNSAF2013-43506-R, and Comunidad de Madrid S2010/BMD-2326. G.S. is an investigator of the Ramón y Cajal Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ISCIII,PI10/01692,Miguel Marcos,PI16/01548,Miguel Marcos,Gerencia regional de salud,junta de castilla y león,GRS 681/A/11,Lourdes Hernández-Cosido,J.-L. T,Lourdes Hernández-Cosido,Gerencia Regional de Salud,Junta de Castilla y León,GRS 1587/A/17,Jorge-Luis Torres,GRS1356/A/16,Jorge-Luis Torres
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

PPAR-γ Gene Expression in Human Adipose Tissue Is Associated with Weight Loss After Sleeve Gastrectomy

  • Torres, Jorge-Luis
  • Usategui-Martín, Ricardo
  • Hernández-Cosido, Lourdes
  • Bernardo, Edgar
  • Manzanedo-Bueno, Laura
  • Hernández-García, Ignacio
  • Mateos-Díaz, Ana-María
  • Rozo, Orlando
  • Matesanz, Nuria
  • Salete-Granado, Daniel
  • Chamorro, Antonio-Javier
  • Carbonell, Cristina
  • Garcia-Macia, Marina
  • González-Sarmiento, Rogelio
  • Sabio, Guadalupe
  • Muñoz-Bellvís, Luis
  • Marcos, Miguel
Background The peroxisome proliferator-activated receptor (PPAR)-γ plays a key role in adipose tissue differentiation and fat metabolism. However, it is unclear which factors may regulate its expression and whether obese patients have changes in adipose tissue expression of PPAR-γor potential regulators such as miR-27. Thus, our aims were to analyze PPAR-γ and miR-27 expression in adipose tissue of obese patients, and to correlate their levels with clinical variables. Subjects and Methods. We included 43 morbidly obese subjects who underwent sleeve gastrectomy (31 of them completed 1-year follow-up) and 19 non-obese subjects. mRNA expression of PPAR-γ1 and PPAR-γ2, miR-27a, and miR-27b was measured by qPCR in visceral and subcutaneous adipose tissue. Clinical variables and serum adipokine and hormone levels were correlated with PPAR-γ and miR-27 expression. In addition, a systematic review of the literature regarding PPAR-γ expression in adipose tissue of obese patients was performed. Results We found no differences in the expression of PPAR-γ and miR-27 in adipose tissue of obese patients vs. controls. The literature review revealed discrepant results regarding PPAR-γ expression in adipose tissue of obese patients. Of note, we described a significant negative correlation between pre-operative PPAR-γ1 expression in adipose tissue of obese patients and post-operative weight loss, potentially linked with insulin resistance markers. Conclusion PPAR-γ1 expression in adipose tissue is associated with weight loss after sleeve gastrectomy and may be used as a biomarker for response to surgery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-Term Mortality of Patients with an Alcohol-Related Wernicke-Korsakoff Syndrome

  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Zuluaga Cruz, Andrea Paola|||0000-0002-3003-4856
  • Fuster, Daniel|||0000-0003-1262-5860
  • Rivas, Inmaculada|||0000-0003-2633-5530
  • Tor Aguilera, Jordi|||0000-0002-5355-9110
  • Marcos, Miguel|||0000-0003-1269-4487
  • Chamorro, Antonio-J.|||0000-0002-2345-2873
  • Muga, Roberto|||0000-0001-6301-431X
Aims: To characterize a series of contemporary patients with alcohol-related Wernicke's encephalopathy (WE) or Korsakoff's syndrome (KS) and to update the current prognosis of disease. Methods: Retrospective and prospective study of patients diagnosed with an alcohol-related WE or KS between 2002 and 2011 in a tertiary hospital. Socio-demographic, alcohol use characteristics, signs and symptoms, co-morbidity and blood parameters were obtained at admission. Patients were followed up until 2013 and causes of death were ascertained through the review of charts. Results: Sixty-one patients were included (51 with WE and 10 with KS). Among patients with WE, 78% were men and age at diagnosis was 57 years (interquartile range (IQR): 49-66). Twenty-three percent fulfilled the classic WE triad. Regarding Caine's criteria for WE, 70.6% presented with at least two out of four signs or symptoms. Median follow-up of patients with WE syndrome was 5.3 years (IQR: 2.6-8.8), the cumulated mortality was 45% and death rate of 7.4 × 100 person-years (95% confidence interval (CI): 4.8-10.9). Overall, 50% of patients would be expected to die within 8 years of WE episode and main causes of death included serious bacterial infections (44.5%) and cancer (33.3%). Conclusions: Survival of patients with an alcohol-related Wernicke-Korsakoff syndrome is poor; pursuing treatment of alcohol use disorder and early diagnosis of thiamine deficiency is a priority for improving clinical outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Treatment variability and its relationships to outcomes among patients with Wernicke's encephalopathy, A multicenter retrospective study

  • Novo-Veleiro, Ignacio|||0000-0003-0948-2440
  • Mateos-Díaz, Ana-M.
  • Rosón-Hernández, Beatriz|||0000-0003-3568-2294
  • Medina-García, José A.
  • Muga, Roberto|||0000-0001-6301-431X
  • Fernández Solá, Joaquim|||0000-0002-3218-0582
  • Martín-González, Candelaria|||0000-0002-4702-1840
  • Seco-Hernández, Elena
  • Suárez-Cuervo, Carlos
  • Monte Secades, Rafael
  • Machado-Prieto, Begoña
  • Puerta-Louro, Rubén
  • Prada González, Cristina|||0000-0002-5780-0047
  • Fernández Rial, Álvaro
  • Sabio Repiso, Patricia|||0000-0002-1878-8794
  • Vázquez-Vigo, Rocío
  • Antolí-Royo, Ana Cristina|||0000-0001-6273-9618
  • Gomila, Aina|||0000-0001-6979-9269
  • Felipe-Pérez, Nieves C.
  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Antúnez-Jorge, Emilia
  • Fernández-Rodríguez, Camino-M.
  • Alvela-Suárez, Lucia
  • Fidalgo-Navarro, Alba
  • Castro, Joaquin
  • Polvorosa-Gómez, María-A.
  • Del Valle-Sánchez, Mario
  • López-Castro, José|||0000-0002-8402-3423
  • Chamorro, Antonio-J.|||0000-0002-2345-2873
  • Marcos, Miguel|||0000-0003-1269-4487
Background: Despite guidelines and recommendations, Wernicke's encephalopathy (WE) treatment lacks evidence, leading to clinical practice variability. Aims: Given the overall lack of information on thiamine use for WE treatment, we analyzed data from a large, well-characterized multicenter sample of patients with WE, examining thiamine dosages; factors associated with the use of different doses, frequencies, and routes; and the influence of differences in thiamine treatment on the outcome. Methods: This retrospective study was conducted with data from 443 patients from 21 centers obtained from a nationwide registry of the Spanish Society of Internal Medicine (from 2000 to 2012). Discharge codes and Caine criteria were applied for WE diagnosis, and treatment-related (thiamine dosage, frequency, and route of administration) demographic, clinical, and outcome variables were analyzed. Results: We found marked variability in WE treatment and a low rate of high-dose intravenous thiamine administration. Seventy-eight patients out of 373 (20.9%) received.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy, A Multicenter Observational Study

  • Novo-Veleiro, Ignacio|||0000-0003-0948-2440
  • Herrera Flores, Javier
  • Rosón-Hernández, Beatriz|||0000-0003-3568-2294
  • Medina-García, José-A.
  • Muga, Roberto|||0000-0001-6301-431X
  • Fernández Solá, Joaquim|||0000-0002-3218-0582
  • Martín-González, M.
  • Seco-Hernández, Elena
  • Suárez-Cuervo, Carlos
  • Mateos-Díaz, Ana-M.
  • Monte-Secades, Rafael|||0000-0003-4257-2712
  • Machado-Prieto, Begoña
  • Puerta-Louro, Rubén
  • Prada González, Cristina|||0000-0002-5780-0047
  • Fernández-Rial, Álvaro
  • Sabio Repiso, Patricia|||0000-0002-1878-8794
  • Vázquez-Vigo, Rocío
  • Antolí-Royo, Ana Cristina|||0000-0001-6273-9618
  • Gomila, Aina|||0000-0001-6979-9269
  • Felipe-Pérez, Nieves C.
  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Antúnez-Jorge, Emilia
  • Fernández-Rodríguez, Camino M.
  • Alvela-Suárez, Lucia
  • Fidalgo-Navarro, Alba
  • Castro, Joaquín|||0000-0001-6248-3114
  • Polvorosa-Gómez, María A.
  • Del Valle-Sánchez, Mario
  • López-Castro, José|||0000-0002-8402-3423
  • Chamorro, Antonio-J.|||0000-0002-2345-2873
  • Marcos, Miguel|||0000-0003-1269-4487
Background: data regarding the association between Wernicke encephalopathy (WE) and alcoholic liver disease (ALD) are scarce in spite of alcohol consumption being the main risk factor for WE. Aims: to describe the frequency of ALD in a cohort of patients diagnosed with WE and alcohol use disorders (AUDs) and to compare the characteristics of WE patients with and without ALD. Methods: we conducted an observational study in 21 centers through a nationwide registry of the Spanish Society of Internal Medicine. WE Caine criteria were applied and demographic, clinical, and outcome variables were analyzed. Results: 434 patients were included in the study, of which 372 were men (85.7%), and the mean age was 55 ± 11.8 years. ALD was present in 162 (37.3%) patients and we found a higher percentage of cases with tremor, flapping and hallucinations in the ALD group. A total of 22 patients (5.0%) died during admission (7.4% with ALD vs 3.7% without ALD; P = 0.087). Among the ALD patients, a relationship between mortality and the presence of anemia (Odds ratio [OR]=4.6 Confidence interval [CI]95% 1.1-18.8; P = 0.034), low level of consciousness (OR=4.9 CI95% 1.1-21.2; P = 0.031) and previous diagnosis of cancer (OR=10.3 CI95% 1.8-59.5; P = 0.009) was detected. Complete recovery was achieved by 27 patients with ALD (17.8%) and 71 (27.8%) without ALD (P = 0.030). Conclusion: the association of WE and ALD in patients with AUDs is frequent and potentially linked to differences in clinical presentation and to poorer prognosis, as compared to alcoholic patients with WE without ALD.